SOLM Stock Overview
Engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
SOL S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €36.75 |
| 52 Week High | €36.75 |
| 52 Week Low | €28.10 |
| Beta | 0.49 |
| 1 Month Change | 0% |
| 3 Month Change | 6.37% |
| 1 Year Change | n/a |
| 3 Year Change | 91.61% |
| 5 Year Change | 248.67% |
| Change since IPO | 460.21% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SOLM | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 0.4% |
| 1Y | n/a | -24.0% | 3.3% |
Return vs Industry: Insufficient data to determine how SOLM performed against the UK Chemicals industry.
Return vs Market: Insufficient data to determine how SOLM performed against the UK Market.
Price Volatility
| SOLM volatility | |
|---|---|
| SOLM Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.4% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: SOLM's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine SOLM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1927 | 7,015 | Aldo Romario | www.solgroup.com |
SOL S.p.A. engages in the applied research, production, and marketing of technical and medical gases in Italy and internationally. The company offers oxygen, nitrogen, argon, hydrogen, carbon and sulphur dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous and liquid helium; gas for electronics; and ammonia and combustible gases for industrial use and liquefied natural gas. It also provides oxygen therapy, home mechanical ventilation, and aerosol therapy services, as well as the diagnosis and treatment of respiratory sleep disorders; services for artificial nutrition, insulin therapy with pumps, and immunotherapy, as well as services for the treatment of pain and Parkinson's disease; home healthcare and social care services; telemedicine and digital services; and healthcare aids.
SOL S.p.A. Fundamentals Summary
| SOLM fundamental statistics | |
|---|---|
| Market cap | €3.29b |
| Earnings (TTM) | €141.04m |
| Revenue (TTM) | €1.55b |
23.3x
P/E Ratio2.1x
P/S RatioIs SOLM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOLM income statement (TTM) | |
|---|---|
| Revenue | €1.55b |
| Cost of Revenue | €1.17b |
| Gross Profit | €375.98m |
| Other Expenses | €234.94m |
| Earnings | €141.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.56 |
| Gross Margin | 24.27% |
| Net Profit Margin | 9.10% |
| Debt/Equity Ratio | 55.0% |
How did SOLM perform over the long term?
See historical performance and comparisonDividends
1.0%
Current Dividend Yield24%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/10/11 12:30 |
| End of Day Share Price | 2024/07/15 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SOL S.p.A. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catharina Claes | Berenberg |
| Giovanni Selvetti | Berenberg |
| Massimo Bonisoli | Equita SIM S.p.A. |